In all studied scenarios, PSA screening appeared more favorable for Black men than for the general population.
Quick discharge of residual stones from the urinary tract is warranted after lithotripsy.
Although most men with low-risk prostate cancer are now managed initially with active surveillance, use of this approach remains suboptimal, according to investigators.
Positive surgical margins in patients undergoing robotic partial nephrectomy for renal tumors are associated with adverse oncologic outcomes, a study revealed.
An interim analysis suggests that axitinib given to patients with complex clear cell renal cell carcinoma tumors significantly reduces tumor size and complexity.
New findings challenge recommendations from the European Association of Urology.
Among donor selection criteria, COVID-19-positive deceased donors could not have significant primary or secondary kidney injury.
The presence of perineural invasion in a prostate biopsy has important implications for active surveillance.
Investigators urge health care professionals who manage patients with ED to discuss the risk of future cardiovascular disease.
Active surveillance appears to be a safe treatment option for low- and very low-risk prostate cancer, regardless of race, according to investigators.
A study examined bladder cancer risk and mortality among nearly 100,000 men from Ontario, Canada, who received 5-alpha reductase inhibitors.
Findings may inform surveillance strategies and improve treatment outcomes.
Some patients with a negative mpMRI while on prostate cancer active surveillance may be able to defer biopsy, according to investigators.
Approximately one-quarter of patients aged 80 years or older with upper tract urothelial carcinoma are managed expectantly, data show.
In a Japanese study, men with vs without OAB had a significantly higher visceral fat area and visceral fat volume.
COVID-19-associated cystitis appears to be a common problem among infected individuals.
Further studies are needed to evaluate oncologic outcomes after postoperative radiation therapy.
Efforts to reduce obesity may cut the prevalence of these urological conditions.
Investigators report a 24-month recurrence-free survival rate of 82% with the use of intravesical gemcitabine/docetaxel following complete transurethral resection of bladder tumor.
Study reveals factors that could distinguish PSA bounce from biochemical recurrence after stereotactic body radiation therapy for prostate cancer.